NEW YORK, Feb 8 – Hyseq’s dwindling cash reserves notwithstanding, many investors and analysts expressed confidence that CEO George Rathmann would recruit the necessary financing to keep the company afloat.

The Sunnyvale, Calif.-based biopharmaceutical company said this morning that its reserves had dropped to just $2.7 million at the end of 2000, down from $30 million a year previously, and that Rathmann would extend a $20 million line of credit to help finance the company’s drug development efforts.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

An opinion piece at Bloomberg discusses China's stance on genomic research.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.